Related Experiment Video
Updated: Jul 25, 2025
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
New approaches in childhood asthma treatment
Riccardo Castagnoli1,2, Ilaria Brambilla1,2, Mattia Giovannini3,4
1Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia.
Insights
Recent advances in pediatric asthma management include new anti-inflammatory treatments and biological therapies for severe cases. Further research is needed to guide optimal treatment selection and identify biomarkers for personalized pediatric asthma care.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Pediatric asthma management has evolved with updated guidelines emphasizing anti-inflammatory treatments.
- Symptomatic bronchodilation as monotherapy is no longer recommended for mild asthma.
- Biological therapies have emerged as a significant advancement for severe, uncontrolled pediatric asthma.
Conclusions:
- Clinicians require more evidence to guide treatment choices, especially for severe pediatric asthma.
- Identifying predictive biomarkers is crucial for selecting appropriate innovative therapies.
- Personalized medicine approaches are increasingly important in pediatric asthma care.
Purpose Of Review:
This review aims to summarize the most recent advances in asthma management, focusing on novel approaches to pediatric asthma.
Recent Findings:
In recent years, the therapeutic tools for pediatric asthma have expanded significantly for both the nonsevere and severe forms. The use of anti-inflammatory treatment, even for the mildest cases, and the withdrawal of symptomatic bronchodilation as monotherapy have been included in the most recent guidelines. Also, different biological therapies have revolutionized the therapeutical approach for severe uncontrolled asthma in children and adolescents.
Summary:
With the expanding landscape of novel therapeutic approaches for pediatric asthma, further evidence is needed to help clinicians choose the best option for patients, particularly those with severe asthma. The identification of novel predictive biomarkers may also help pediatricians in selecting children and adolescents for innovative therapies.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:29Asthma-I: Introduction
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...